Company profile: OxSonics Therapeutics
1.1 - Company Overview
Company description
- Provider of a proprietary ultrasound-enabled drug delivery platform, SonoTran, designed to enhance penetration and distribution of anti-cancer agents within solid tumors. Offerings include SonoTran Particles with stabilised gas bubbles for cavitation, the SonoTran System for imaging, treatment and monitoring, a development pipeline with oncology drugs, and partnering services for pharmaceutical and biotech companies.
Products and services
- SonoTran® System: Ultrasound-based device that works with SonoTran® Particles to image, treat, and monitor target tissue regions in oncology settings
- SonoTran® Platform: Proprietary drug delivery platform using ultrasound-activated particles to increase dose and distribution of anti-cancer agents within solid tumours, aiming for a step-change therapeutic index without drug reformulation costs or delays
- SonoTran® Particles: Cavitation-enabled particles carrying a stabilised gas bubble that, when exposed to ultrasound, enhance the transport of anti-cancer drugs into solid tumours
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to OxSonics Therapeutics
Fusion Pharmaceuticals
HQ: Canada
Website
- Description: Provider of clinical-stage radiopharmaceuticals and targeted alpha therapies for oncology, leveraging deep radiochemistry and Fast-Clear Linker Technology to improve safety. Pipeline includes FPI-2265 targeting PSMA in prostate cancer (Phase 2), FPI-1434 targeting IGF-1R, and FPI-2059 targeting NTSR1. Offers manufacturing expertise to build commercial supply chains.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Fusion Pharmaceuticals company profile →
Somatex
HQ: Germany
Website
- Description: Provider of medical devices, located in Berlin.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Somatex company profile →
Gennao Bio
HQ: United States
Website
- Description: Provider of genetic medicines developing targeted nucleic acid therapeutics for muscle diseases, featuring GMAB, a non-viral, cell-penetrating antibody technology that delivers nucleic acid payloads into cells targeting cancer and skeletal muscle disorders, and GMAB ADC for solid tumors, an antibody-drug conjugate demonstrated in preclinical studies to deliver cytotoxic drugs directly to tumor cells.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Gennao Bio company profile →
Spectrum Pharmaceuticals
HQ: United States
Website
- Description: Provider of novel, targeted biopharmaceuticals focused on acquiring, developing, and commercializing therapies in oncology and hematology. Products include ROLVEDON (reduces severe neutropenia in non-myeloid malignancies on myelosuppressive drugs), SYMPAZAN (Lennox-Gastaut seizures), SPRIX (short-term pain), Otrexup (RA, psoriasis), Cambia (acute migraine), and INDOCIN (RA, AS, OA).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Spectrum Pharmaceuticals company profile →
Dune Medical
HQ: United States
Website
- Description: Provider of intraoperative, real-time cancer detection devices using proprietary tissue characterization technology, enabling surgeons and radiologists to detect cancer in real time with potential for broad diagnostic and therapeutic applications.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Dune Medical company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for OxSonics Therapeutics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to OxSonics Therapeutics
2.2 - Growth funds investing in similar companies to OxSonics Therapeutics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for OxSonics Therapeutics
4.2 - Public trading comparable groups for OxSonics Therapeutics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →